Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G02AX	GYNOCIN	G	Oxytocin - 10IU/ml	10IU/ml	Injectable concentrate for solution	626,231 L.L
G02AX	GYNOCIN	G	Oxytocin - 5IU/0.5ml	5IU/0.5ml	Injectable concentrate for solution	313,115 L.L
G03CC06	GYNOFLOR	B	Estriol - 0.03mg, Lactobacillus acidophillus - 10 MIU		Tablet	813,025 L.L
G03DA04	GESTA 400	G	Progesterone - 400mg	400mg	Pessary	1,083,137 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 900IU/1.5ml	66mcg/1.5ml	Injectable solution	29,625,401 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 450IU/0.75ml	450IU/0.75ml	Injectable solution	14,813,959 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 300IU/0.5ml	300IU/0.5ml	Injectable solution	10,305,698 L.L
H01AC01	GENOTROPIN	BioTech	Somatropin recombinant - 5.3mg/1.15ml	5.3mg/1.15ml	Injectable powder for solution+diluent	4,724,854 L.L
H01AC01	GENOTROPIN GOQUICK	BioTech	Somatropin recombinant - 12mg/ml	12mg/ml	Injectable powder for solution+diluent	25,170,264 L.L
H04AA01	GLUCAGEN	BioTech	Glucagon HCl - 1mg	1mg	Injectable powder for solution+diluent	1,343,444 L.L
J01AA02	GRANUDOXY	G	Doxycycline (monohydrate) - 100mg	100mg	Tablet, film-scored	318,491 L.L
J01AA02	GRANUDOXY	G	Doxycycline (monohydrate) - 100mg	100mg	Tablet, film-scored	282,207 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 80mg/2ml	80mg/2ml	Injectable solution	721,643 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 80mg/2ml	80mg/2ml	Injectable solution	721,643 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 40mg/2ml	40mg/2ml	Injectable solution	643,701 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 40mg/2ml	40mg/2ml	Injectable solution	643,701 L.L
J05AR18	GENVOYA	B	Emtricitabine - 200mg, Tenofovir alafenamide - 10mg, Elvitegravir - 150mg, Cobicistat - 150mg		Tablet, film coated	77,789,650 L.L
J06BA02	GAMUNEX-C	BioHuman	Human normal immunoglobulin G - 10%	10%	Injectable solution	39,990,287 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml		Injectable suspension	791,523 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml		Injectable suspension	14,139,396 L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 200mg/20ml	200mg/20ml	Injectable concentrated solution	2,121,927 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,490,321 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,617,986 L.L
L01BC05	GEMNIL	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,128,828 L.L
L01BC05	GEMTABINE 200	G	Gemcitabine HCl - 200mg	200mg	Injectable lyophilised powder for solution	1,343,843 L.L
L01BC05	GEMCI-CELL	G	Gemcitabine (HCl) - 1g/Vial	1g/Vial	Injectable concentrate for solution	9,326,123 L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 1g/100ml	1g/100ml	Injectable concentrated solution	7,512,674 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 1000mg	1000mg	Injectable powder for solution	4,942,653 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 1g	1g	Injectable powder for solution	5,843,027 L.L
L01BC05	GEMNIL	G	Gemcitabine (HCl) - 1g	1g	Injectable powder for solution	3,369,013 L.L